ロード中...
Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
BACKGROUND: Preclinical evidence suggests that modulation of the gut microbiome could represent a new therapeutic target in nonalcoholic fatty liver disease (NAFLD). OBJECTIVES: The aim of this study was to evaluate the most current evidence for liver-specific and metabolic effects of microbiome-tar...
保存先:
| 出版年: | Am J Clin Nutr |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599739/ https://ncbi.nlm.nih.gov/pubmed/31124558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajcn/nqz042 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|